DHR · NYSE · STOCK
Danaher (DHR) Stock Analysis
$219.80
52W $160.93 – $242.80
59/100
$154.57B
38.9
0.80
⚠
Buy rating, but near-term risk/reward is unfavorable
The long-term recommendation is based on the composite investment score. The near-term risk/reward is based on nearby support and resistance levels. These can differ when a strong company trades close to resistance with support further below.
Is DHR Bullish or Bearish?
Bullish.
Innellis AI committee rates Danaher Corporation (DHR) Buy with a composite score of 59/100
, based on 5 analysts with 60% agreement.
Last updated October 10, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +15.83 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -4.17 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Macro Analyst sees a compelling case. Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Price structure making higher highs and higher lows — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
Bear Case
- P/E of 38.5 is moderate-to-rich — Value
- MACD histogram negative -- bearish momentum — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 10, 2026
Overall Committee Score
59/100
Agreement
60%
Analysts
5
Conviction
Moderate
Sector Rank
Top 36%
of 192 Healthcare peers
Value Analyst
neutral
55
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
− P/E of 38.5 is moderate-to-rich
Growth Analyst
bullish
60
/ 100 · Moderate confidence
Strong, accelerating growth with consistent execution
+ 5 consecutive earnings beats -- consistent execution
Technical Analyst
neutral
58
/ 100 · High confidence
Mixed or range-bound price action
+ Price structure making higher highs and higher lows
− MACD histogram negative -- bearish momentum
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
neutral
58
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager
bearish
30
/ 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Investment Thesis Evolution
Committee score moved marginally from 59.2 to 59.2.
- New bearish signals: 1 appeared.
- Bearish pressure eased: 1 signal(s) disappeared.
Analyst-level changes:
- Value Analyst: +1 bearish signal(s).
Comparing 2026-10-09 to 2026-10-10 (1 day apart).
Technical Analysis
RSI (14)
54.4
Neutral
MACD Histogram
-0.564
Bearish Momentum
Trend Direction
Uptrend
Weekly: Sideways
Market Structure
Hh Hl
Support
$217.89
Resistance
$220.66
Bollinger %B
0.60
Inside Bands
Price vs Moving Averages
EMA 9
$218.39
Above
EMA 21
$216.62
Above
EMA 50
$210.89
Above
EMA 200
$203.12
Above
Fundamental Analysis
Valuation
44
Growth
65
Profitability
63
Financial Health
85
Cash Flow
70
Valuation
P/E Ratio
38.9×
P/B Ratio
2.95×
PEG Ratio
2.00
Dividend Yield
0.69%
52W High
$242.80
52W Low
$160.93
Quality & Growth
ROE
687.9%
ROA
433.0%
Gross Margin
5851.4%
Operating Margin
2042.1%
Revenue Growth YoY
—
Debt / Equity
0.51
AI Fundamental Assessment
P/E ratio of 38.9 (rich relative to a 15-40x range); Price-to-book of 2.9x; PEG ratio of 2.0 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 6.9%; Return on assets of 4.3%; Net margin of 15.9%; Gross margin of 58.5%; Current ratio of 1.65 (healthy short-term liquidity); Debt-to-equity of 0.51; Free cash flow per share is positive (7.75); Most recent quarter beat estimates by 4.7%; 5 consecutive earnings beats; EPS growth roughly steady (-7.6% -> -5.8% QoQ); Average YoY EPS growth of 7.8%; Analyst estimates falling over recent quarters
Get the Full DHR Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →